Smith+Nephew Records Early Wins in Ortho Turnaround

Smith+Nephew reported 3Q22 orthopedic sales of $849.3 million, -2.2% compared to the third quarter of 2021. Excluding the impact of currency headwinds, the company achieved underlying growth of 2.1% in its orthopedic franchise and 7.1% in sports medicine.

Volume-based procurement (VBP) in China hurt orthopedic sales significantly....

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0